Plenary: Friday Morning
Stars at Night Ballroom
Plenary
Information
Continuing Medical Education
CME
Translation
Audio and Captioning
Format
In PersonLive StreamOn Demand
Plenary: Friday Morning
Crossfire: Controversies in Urology: Ileal Conduit vs Neobladder: 68-year-old Man Who Wants a Neobladder but Is Unsure About Catheterizing
Friday, May 3, 2024 7:30 AM to 8:00 AM
Stars at Night Ballroom
Panel Discussion: 49-year-old Woman with Symptomatic Large-volume Upper Tract Urothelial Carcinoma
Friday, May 3, 2024 8:00 AM to 8:25 AM
Stars at Night Ballroom
Panel Discussion: 55-year-old Male with BCR After Local Therapy: Risk Stratification, Markers, Management of Low and High-risk
Friday, May 3, 2024 8:25 AM to 8:50 AM
Stars at Night Ballroom
Second Opinion Cases: GG1 with Sacral Abnormality on Bone Scan and PSMA PET Started on ADT by Dx Urologist; Referred for Treatment of m1b
Friday, May 3, 2024 8:50 AM to 9:20 AM
Stars at Night Ballroom
State-of-the-art Lecture: Prostate Cancer Screening in High-risk Groups
Friday, May 3, 2024 9:20 AM to 9:35 AM
Stars at Night Ballroom
Panel Discussion: Increasing Prostate Cancer Screening in Black and Brown Communities
Friday, May 3, 2024 9:35 AM to 10:00 AM
Stars at Night Ballroom
AUA Guidelines: Salvage Therapy for Prostate Cancer
Friday, May 3, 2024 10:00 AM to 10:15 AM
Stars at Night Ballroom
P2s: Paradigm-shifting, Practice-changing Clinical Trials in Urology
Friday, May 3, 2024 10:15 AM to 11:30 AM
Stars at Night Ballroom
P2s: Paradigm-shifting, Practice-changing Clinical Trials in Urology: TAR-200 in patients with Bacillus Calmette–Guérin-unresponsive high-risk non–muscle-invasive bladder cancer: Results from SunRISe-1 study
Friday, May 3, 2024 10:15 AM to 10:23 AM
Stars at Night Ballroom
P2s: Paradigm-shifting, Practice-changing Clinical Trials in Urology: Pivotal Results from BOND-003: A Phase 3, Single-arm Study of Intravesical Cretostimogene Grenadenorepvec for the Treatment of High Risk, BCG-Unresponsive Non-Muscle Invasive Bladder C
Friday, May 3, 2024 10:23 AM to 10:31 AM
Stars at Night Ballroom
P2s: Paradigm-shifting, Practice-changing Clinical Trials in Urology: LEGEND: a phase 1/2 study of EG-70 (detalimogene voraplasmid), a novel, non-viral intravesical gene therapy for patients with BCG-unresponsive non-muscle invasive bladder cancer with ca
Friday, May 3, 2024 10:31 AM to 10:39 AM
Stars at Night Ballroom
P2s: Paradigm-shifting, Practice-changing Clinical Trials in Urology: SWOG S1011 – Subgroup analysis of the Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Lymphadenectomy Performed at Time of Radical Cystectomy for Muscl
Friday, May 3, 2024 10:39 AM to 10:47 AM
Stars at Night Ballroom
P2s: Paradigm-shifting, Practice-changing Clinical Trials in Urology: Efficacy of [177Lu]Lu-PSMA-617 versus ARPI change in taxane-naive patients with metastatic castration-resistant prostate cancer by pre-randomization ARPI (PSMAfore)
Friday, May 3, 2024 10:47 AM to 10:55 AM
Stars at Night Ballroom
P2s: Paradigm-shifting, Practice-changing Clinical Trials in Urology: The next generation trial: Assessing 18F-PSMA-1007 PET and MRI in primary staging of prostate cancer patients
Friday, May 3, 2024 10:55 AM to 11:03 AM
Stars at Night Ballroom
P2s: Paradigm-shifting, Practice-changing Clinical Trials in Urology: HIFI trial: HIFU vs Radical prostatectomy for localized Prostate cancer in 3328 cases. Final results.
Friday, May 3, 2024 11:11 AM to 11:19 AM
Stars at Night Ballroom
P2s: Paradigm-shifting, Practice-changing Clinical Trials in Urology: Apalutamide and androgen deprivation therapy for the treatment of high-risk localized prostate cancer following radical prostatectomy in Apa-RP: a multicenter, open-label, single-arm ph
Friday, May 3, 2024 11:19 AM to 11:27 AM
Stars at Night Ballroom
